Skip to main content
Top
Published in: Diabetologia 11/2009

01-11-2009 | Article

Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRβ/IRS-1 and Akt

Authors: M. A. Carvalho-Filho, E. R. Ropelle, R. J. Pauli, D. E. Cintra, D. M. L. Tsukumo, L. R. Silveira, R. Curi, J. B. C. Carvalheira, L. A. Velloso, M. J. A. Saad

Published in: Diabetologia | Issue 11/2009

Login to get access

Abstract

Aim/hypothesis

High-dose aspirin treatment improves fasting and postprandial hyperglycaemia in patients with type 2 diabetes, as well as in animal models of insulin resistance associated with obesity and sepsis. In this study, we investigated the effects of aspirin treatment on inducible nitric oxide synthase (iNOS)-mediated insulin resistance and on S-nitrosylation of insulin receptor (IR)-β, IRS-1 and protein kinase B (Akt) in the muscle of diet-induced obese rats and also in iNos (also known as Nos2)−/− mice on high fat diet.

Methods

Aspirin (120 mg kg−1 day−1 for 2 days) or iNOS inhibitor (L-NIL; 80 mg/kg body weight) were administered to diet-induced obese rats or mice and iNOS production and insulin signalling were investigated. S-nitrosylation of IRβ/IRS-1 and Akt was investigated using the biotin switch method.

Results

iNOS protein levels increased in the muscle of diet-induced obese rats, associated with an increase in S-nitrosylation of IRβ, IRS-1 and Akt. These alterations were reversed by aspirin treatment, in parallel with an improvement in insulin signalling and sensitivity, as measured by insulin tolerance test and glucose clamp. Conversely, while aspirin reversed the increased phosphorylation of IκB kinase β and c-Jun amino-terminal kinase, as well as IRS-1 serine phosphorylation in diet-induced obese rats and iNos −/− mice on high-fat diet, these alterations were not associated with the improvement of insulin action induced by this drug.

Conclusions/interpretation

Our data demonstrate that aspirin treatment not only reduces iNOS protein levels, but also S-nitrosylation of IRβ, IRS-1 and Akt. These changes are associated with improved insulin resistance and signalling, suggesting a novel mechanism of insulin sensitisation evoked by aspirin treatment.
Literature
1.
go back to reference Sethi JK, Hotamisligil GS (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10:19–29CrossRefPubMed Sethi JK, Hotamisligil GS (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10:19–29CrossRefPubMed
2.
go back to reference Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336CrossRefPubMed Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336CrossRefPubMed
3.
go back to reference Perreault M, Marette A (2001) Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138–1143CrossRefPubMed Perreault M, Marette A (2001) Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138–1143CrossRefPubMed
4.
go back to reference Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673–1677CrossRefPubMed Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673–1677CrossRefPubMed
5.
go back to reference Barreiro GC, Prattali RR, Caliseo CT et al (2004) Aspirin inhibits serine phosphorylation of IRS-1 in muscle and adipose tissue of septic rats. Biochem Biophys Res Commun 320:992–997CrossRefPubMed Barreiro GC, Prattali RR, Caliseo CT et al (2004) Aspirin inhibits serine phosphorylation of IRS-1 in muscle and adipose tissue of septic rats. Biochem Biophys Res Commun 320:992–997CrossRefPubMed
6.
go back to reference Hundal RS, Petersen KF, Mayerson AB et al (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321–1326PubMed Hundal RS, Petersen KF, Mayerson AB et al (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321–1326PubMed
7.
go back to reference Kim JK, Kim YJ, Fillmore JJ et al (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437–446PubMed Kim JK, Kim YJ, Fillmore JJ et al (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437–446PubMed
8.
go back to reference Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J (2003) Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278:24944–24950CrossRefPubMed Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J (2003) Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278:24944–24950CrossRefPubMed
9.
go back to reference Carvalho-Filho MA, Ueno M, Hirabara SM et al (2005) S-nitrosylation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54:959–967CrossRefPubMed Carvalho-Filho MA, Ueno M, Hirabara SM et al (2005) S-nitrosylation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54:959–967CrossRefPubMed
10.
go back to reference Carvalho-Filho MA, Ueno M, Carvalheira JB, Velloso LA, Saad MJ (2006) Targeted disruption of iNOS prevents LPS-induced S-nitrosylation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am J Physiol Endocrinol Metab 291:E476–E482CrossRefPubMed Carvalho-Filho MA, Ueno M, Carvalheira JB, Velloso LA, Saad MJ (2006) Targeted disruption of iNOS prevents LPS-induced S-nitrosylation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am J Physiol Endocrinol Metab 291:E476–E482CrossRefPubMed
11.
go back to reference Cieslik K, Zhu Y, Wu KK (2002) Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway. J Biol Chem 277:49304–49310CrossRefPubMed Cieslik K, Zhu Y, Wu KK (2002) Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway. J Biol Chem 277:49304–49310CrossRefPubMed
12.
go back to reference Katsuyama K, Shichiri M, Kato H, Imai T, Marumo F, Hirata Y (1999) Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 140:2183–2190CrossRefPubMed Katsuyama K, Shichiri M, Kato H, Imai T, Marumo F, Hirata Y (1999) Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 140:2183–2190CrossRefPubMed
13.
go back to reference Wang Z, Brecher P (1999) Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase. Hypertension 34:1259–1264PubMed Wang Z, Brecher P (1999) Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase. Hypertension 34:1259–1264PubMed
14.
go back to reference Sugita H, Fujimoto M, Yasukawa T et al (2005) Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 280:14203–14211CrossRefPubMed Sugita H, Fujimoto M, Yasukawa T et al (2005) Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 280:14203–14211CrossRefPubMed
15.
go back to reference Bonora E, Moghetti P, Zancanaro C et al (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68:374–378CrossRefPubMed Bonora E, Moghetti P, Zancanaro C et al (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68:374–378CrossRefPubMed
16.
go back to reference Prada PO, Zecchin HG, Gasparetti AL et al (2005) Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146:1576–1587CrossRefPubMed Prada PO, Zecchin HG, Gasparetti AL et al (2005) Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146:1576–1587CrossRefPubMed
17.
go back to reference Saad MJ, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR (1992) Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1839–1849CrossRefPubMed Saad MJ, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR (1992) Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1839–1849CrossRefPubMed
18.
go back to reference Tremblay F, Lavigne C, Jacques H, Marette A (2001) Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 50:1901–1910CrossRefPubMed Tremblay F, Lavigne C, Jacques H, Marette A (2001) Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 50:1901–1910CrossRefPubMed
19.
go back to reference Jaffrey SR, Snyder SH (2001) The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: PL1 Jaffrey SR, Snyder SH (2001) The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: PL1
20.
go back to reference Martinez-Ruiz A, Lamas S (2004) Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys 423:192–199CrossRefPubMed Martinez-Ruiz A, Lamas S (2004) Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys 423:192–199CrossRefPubMed
21.
go back to reference Lynge J, Juel C, Hellsten Y (2001) Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters. J Physiol 537:597–605CrossRefPubMed Lynge J, Juel C, Hellsten Y (2001) Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters. J Physiol 537:597–605CrossRefPubMed
22.
go back to reference Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMed Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMed
23.
go back to reference Pollock JS, Forstermann U, Mitchell JA et al (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A 88:10480–10484CrossRefPubMed Pollock JS, Forstermann U, Mitchell JA et al (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A 88:10480–10484CrossRefPubMed
24.
go back to reference Cai D, Yuan M, Frantz DF et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–190CrossRefPubMed Cai D, Yuan M, Frantz DF et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–190CrossRefPubMed
25.
go back to reference Rohl M, Pasparakis M, Baudler S et al (2004) Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113:474–481PubMed Rohl M, Pasparakis M, Baudler S et al (2004) Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113:474–481PubMed
26.
go back to reference Jiang G, Dallas-Yang Q, Liu F, Moller DE, Zhang BB (2003) Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells. J Biol Chem 278:180–186CrossRefPubMed Jiang G, Dallas-Yang Q, Liu F, Moller DE, Zhang BB (2003) Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells. J Biol Chem 278:180–186CrossRefPubMed
27.
go back to reference Prattali RR, Barreiro GC, Caliseo CT et al (2005) Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals. FEBS Lett 579:3152–3158CrossRefPubMed Prattali RR, Barreiro GC, Caliseo CT et al (2005) Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals. FEBS Lett 579:3152–3158CrossRefPubMed
28.
go back to reference Fujimoto M, Shimizu N, Kunii K, Martyn JA, Ueki K, Kaneki M (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54:1340–1348CrossRefPubMed Fujimoto M, Shimizu N, Kunii K, Martyn JA, Ueki K, Kaneki M (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54:1340–1348CrossRefPubMed
29.
go back to reference Taylor BS, Geller DA (2000) Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13:413–424PubMed Taylor BS, Geller DA (2000) Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13:413–424PubMed
30.
go back to reference Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M (2005) S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280:7511–7518CrossRefPubMed Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M (2005) S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280:7511–7518CrossRefPubMed
31.
go back to reference Dallaire P, Bellmann K, Laplante M et al (2008) Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57:1999–2011CrossRefPubMed Dallaire P, Bellmann K, Laplante M et al (2008) Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57:1999–2011CrossRefPubMed
32.
go back to reference Fleischman A, Shoelson SE, Bernier R, Goldfine AB (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31:289–294CrossRefPubMed Fleischman A, Shoelson SE, Bernier R, Goldfine AB (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31:289–294CrossRefPubMed
33.
go back to reference Goldfine AB, Silver R, Aldhahi W et al (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 1:36–43CrossRefPubMed Goldfine AB, Silver R, Aldhahi W et al (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 1:36–43CrossRefPubMed
Metadata
Title
Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRβ/IRS-1 and Akt
Authors
M. A. Carvalho-Filho
E. R. Ropelle
R. J. Pauli
D. E. Cintra
D. M. L. Tsukumo
L. R. Silveira
R. Curi
J. B. C. Carvalheira
L. A. Velloso
M. J. A. Saad
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1498-1

Other articles of this Issue 11/2009

Diabetologia 11/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.